NCT05871918 2023-05-23
A Multicenter, Randomized, Open, Phase III Trial of ddEC-THPvs Evaluating the Efficacy and Safety of TCHP Neoadjuvant Therapy for HER2-positive Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 3 Unknown